Leal Therapeutics is a biotechnology company dedicated to developing novel precision medicines for patients with high-need central nervous system disorders. Leal was launched in 2021 and is headquartered in Worcester, Mass.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
10/30/24	$45,000,000		Alexandria Venture Investments Chugai Venture Fund Euclidean Capital Newpath Partners OrbiMed Advisors PhiFund	undisclosed
08/17/26	$30,000,000	Series A Extension	Alexandria Venture Investments Chugai Venture Fund Eli Lilly Ventures Euclidean Capital Newpath Partners OrbiMed Advisors PhiFund SV Health Investors	undisclosed